ARM 1 - Physician’s choice of chemotherapy regimens
physician-choice
Patients randomized to the physician-choice chemotherapy arm were treated with one of the regimens from the list of chemotherapies specified per the investigator’s discretion. Patients received treatment as per standard practice and continued on the treatment until hospice or as per investigator’s discretion if having continued response (SD, PR, or CR) and/or clinical benefit. The number of cycles of therapy administered as clinically appropriate was based on the health status, although it was recommended that patients should receive at least 4 cycles of therapy.